126 related articles for article (PubMed ID: 16990769)
21. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
Köhler T; Plettig R; Wetzstein W; Schmitz M; Ritter M; Mohr B; Schaekel U; Ehninger G; Bornhäuser M
Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
[TBL] [Abstract][Full Text] [Related]
22. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
[TBL] [Abstract][Full Text] [Related]
23. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
[TBL] [Abstract][Full Text] [Related]
24. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
[TBL] [Abstract][Full Text] [Related]
25. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
26. CD34+ cord blood DC-induced antitumor lymphoid cells have efficacy in a murine xenograft model of human ALL.
Cullup H; Hsu AK; Kassianos AJ; McDonald K; Radford KJ; Rice AM
J Immunother; 2011 May; 34(4):362-71. PubMed ID: 21499125
[TBL] [Abstract][Full Text] [Related]
27. A functional comparison of mature human dendritic cells prepared in fluorinated ethylene-propylene bags or polystyrene flasks.
Kurlander RJ; Tawab A; Fan Y; Carter CS; Read EJ
Transfusion; 2006 Sep; 46(9):1494-504. PubMed ID: 16965575
[TBL] [Abstract][Full Text] [Related]
28. Generation of antigen-specific cytotoxic T lymphocytes using a leukemic plasmacytoid dendritic cell line as antigen presenting cells.
Yamahira A; Narita M; Nakamura T; Watanabe N; Kaji M; Taniguchi T; Hashimoto S; Furukawa T; Toba K; Aizawa Y; Kuzushima K; Takahashi M
Leuk Res; 2011 Jun; 35(6):793-9. PubMed ID: 21216464
[TBL] [Abstract][Full Text] [Related]
29. [Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen].
He B; Qiu G; Xie X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):974-8. PubMed ID: 15646345
[TBL] [Abstract][Full Text] [Related]
30. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
31. Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukemia.
Pospísilová D; Borovicková J; Poloucková A; Spísek R; Sedivá A; Hrusák O; Starý J; Bartůnková J
Cancer Immunol Immunother; 2002 Apr; 51(2):72-8. PubMed ID: 11904731
[TBL] [Abstract][Full Text] [Related]
32. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
[TBL] [Abstract][Full Text] [Related]
33. Characterization of dendritic-like cells derived from t(9;22) acute lymphoblastic leukemia blasts.
Lee J; Sait SN; Wetzler M
Int Immunol; 2004 Oct; 16(10):1377-89. PubMed ID: 15302850
[TBL] [Abstract][Full Text] [Related]
34. LIGHT, a new TNF superfamily member, is essential for memory T helper cell-mediated activation of dendritic cells.
Morel Y; Truneh A; Costello RT; Olive D
Eur J Immunol; 2003 Nov; 33(11):3213-9. PubMed ID: 14579290
[TBL] [Abstract][Full Text] [Related]
35. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
[TBL] [Abstract][Full Text] [Related]
36. CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells.
Luczyński W; Stasiak-Barmuta A; Iłendo E; Krawczuk-Rybak M; Malinowska I; Mitura-Lesiuk M; Parfieńczyk A; Szymański M
Acta Biochim Pol; 2006; 53(2):377-82. PubMed ID: 16733557
[TBL] [Abstract][Full Text] [Related]
37. Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
Houtenbos I; Westers TM; Dijkhuis A; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
Clin Cancer Res; 2007 Jan; 13(1):307-15. PubMed ID: 17170077
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients.
Maecker B; Mougiakakos D; Zimmermann M; Behrens M; Hollander S; Schrauder A; Schrappe M; Welte K; Klein C
Leukemia; 2006 Apr; 20(4):645-9. PubMed ID: 16498391
[TBL] [Abstract][Full Text] [Related]
39. Generation of lymphocytes potentiated against leukemic lymphoblasts by stimulation using leukemic cell lysate-pulsed dendritic cells in patients with acute lymphoblastic leukemia and measurement of in vitro anti-leukemic cytotoxicity.
Lim JH; Park CJ; Kim MJ; Jang S; Chi HS; Lee JH; Lee JH; Lee KH; Im HJ; Seo JJ
Hematology; 2012 Jan; 17(1):15-22. PubMed ID: 22549443
[TBL] [Abstract][Full Text] [Related]
40. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
Sadeghlar F; Vogt A; Mohr RU; Mahn R; van Beekum K; Kornek M; Weismüller TJ; Branchi V; Matthaei H; Toma M; Schmidt-Wolf IGH; Kalff JC; Strassburg CP; González-Carmona MA
Cancer Immunol Immunother; 2021 May; 70(5):1451-1464. PubMed ID: 33180184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
